-
1
-
-
77952073545
-
Interpretation and utility of drug of abuse immunoassay: Lessons from drug testing surveys
-
Melanson SEF, Baskin L, Magnani B, et al. Interpretation and utility of drug of abuse immunoassay: lessons from drug testing surveys. Arch Pathol Lab Med. 2010;134:735-739.
-
(2010)
Arch Pathol Lab Med.
, vol.134
, pp. 735-739
-
-
Melanson, S.E.F.1
Baskin, L.2
Magnani, B.3
-
2
-
-
79952111304
-
Commonly prescribed medication and potential false-positive drug screens
-
Brahm NC, Yeager LL, Fox MD, et al. Commonly prescribed medication and potential false-positive drug screens. Am J Health Syst Pharm. 2010; 67:1344-1350.
-
(2010)
Am J Health Syst Pharm.
, vol.67
, pp. 1344-1350
-
-
Brahm, N.C.1
Yeager, L.L.2
Fox, M.D.3
-
4
-
-
0028874695
-
Benzathine as a cause for false positive test result for amphetamines
-
Berthier M, Bonneau D, Mura P, et al. Benzathine as a cause for false positive test result for amphetamines. J Pediatr. 1995;127:669-670.
-
(1995)
J Pediatr.
, vol.127
, pp. 669-670
-
-
Berthier, M.1
Bonneau, D.2
Mura, P.3
-
5
-
-
0026694976
-
Metabolites of chlorpromazeine and bromopheniramine may cause false positive urine amphetamine results with monoclonal EMIT DAU immunoassay [Letter]
-
Olsen KM, Gulliksen M, Christophersen AS. Metabolites of chlorpromazeine and bromopheniramine may cause false positive urine amphetamine results with monoclonal EMIT DAU immunoassay [Letter]. Clin Chem. 1992;38:611-612.
-
(1992)
Clin Chem.
, vol.38
, pp. 611-612
-
-
Olsen, K.M.1
Gulliksen, M.2
Christophersen, A.S.3
-
6
-
-
0029068835
-
Bupropion metabolites produce false positive urine amphetamine results [Letter]
-
Nixon AL, Long WH, Puopolo PR, et al. Bupropion metabolites produce false positive urine amphetamine results [Letter]. Clin Chem. 1995;41:955.
-
(1995)
Clin Chem.
, vol.41
, pp. 955
-
-
Nixon, A.L.1
Long, W.H.2
Puopolo, P.R.3
-
7
-
-
0033840185
-
Amphetamine positive toxicology screen secondary to bupropion
-
Weintraub D, Linder MW. Amphetamine positive toxicology screen secondary to bupropion. Depress Anxiety. 2000;12:53-54.
-
(2000)
Depress Anxiety.
, vol.12
, pp. 53-54
-
-
Weintraub, D.1
Linder, M.W.2
-
8
-
-
34447510939
-
Bupropion interference with immunoassays for amphetamines and LSD
-
DOI 10.1097/FTD.0b013e318040adc3, PII 0000769120070600000017
-
Vidal C, Skripuletz T. Bupropion interference with immunoassay for amphetamines and LSD. Ther Drug Monit. 2007;29:373-375. (Pubitemid 47262270)
-
(2007)
Therapeutic Drug Monitoring
, vol.29
, Issue.3
, pp. 373-375
-
-
Vidal, C.1
Skripuletz, T.2
-
9
-
-
80051781486
-
-
Lexington, KY: Neogen Corporation, Lexington, KY; August 27
-
Neogen Amphetamine ULTRA package insert. Lexington, KY: Neogen Corporation, Lexington, KY; August 27, 2008.
-
(2008)
Neogen Amphetamine ULTRA Package Insert
-
-
-
10
-
-
80051782335
-
-
Lexington, KY: Neogen Corporation; August 27
-
Neogen Methamphetamine package insert. Lexington, KY: Neogen Corporation; August 27, 2008.
-
(2008)
Neogen Methamphetamine Package Insert
-
-
-
11
-
-
80051801958
-
-
Lexington, KY: Neogen Corporation; March 24
-
Neogen Amphetamine package insert. Lexington, KY: Neogen Corporation; March 24, 2010.
-
(2010)
Neogen Amphetamine Package Insert
-
-
-
13
-
-
2542457161
-
Bupropion in breast milk: An exposure assessment for potential treatment to prevent post-partum tobacco use
-
DOI 10.1136/tc.2003.004093
-
Haas JS, Kaplan CP, Barenboim D, et al. Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use. Tobacco Control. 2004;13:52-56. (Pubitemid 39456644)
-
(2004)
Tobacco Control
, vol.13
, Issue.1
, pp. 52-56
-
-
Haas, J.S.1
Kaplan, C.P.2
Barenboim, D.3
Jacob III, P.4
Benowitz, N.L.5
|